줄기세포 유래 세포치료제의 개발 전략 및 임상화 과정
분야
의약학 > 기타(의약학)
저자
조명수 ( Myung Soo Cho ) , 유대훈 ( Dae Hoon Yoo ) , 송슬애 ( Seul Ae Song ) , 최영민 ( Young Min Choi )
발행기관
서울대학교 인구의학연구소
간행물정보
인구의학연구논집 2012년, 제25권 27~34페이지(총8페이지)
파일형식
0y500290.pdf [무료 PDF 뷰어 다운로드]
  • ※ 본 자료는 참고용 논문으로 수정 및 텍스트 복사가 되지 않습니다.
  • 구매가격
    4,500원
    적립금
    135원 (구매자료 3% 적립)
    이메일 발송  스크랩 하기
    자료 다운로드  네이버 로그인
    영문초록
    Stem cells are good cell sources for cell replacement therapy of degenerative or incurable disorders. However, there are some limitations such as immune response, differentiation efficiency, safety and ethical issues for clinical application. These barriers must be considered thoroughly from starting point of the investigational study. For clinical application and commercialization of stem cell-derived cell therapy products, strict preparation is required for formal approval of regulatory body at each stage of the clinical process. This preparation process can be another barrier and challenge to the researcher or developer related to stem cell study. However, These challenges will become increasingly important to stem cell research as clinical translation progresses and helpful for birth of authentic novel cell therapy products. In this brief review, we will suggest more effective strategy of the stem cell research and development and introduce the clinical process for cell therapy products briefly.
    사업자등록번호 220-87-87785 대표.신현웅 주소.서울시 서초구 방배로10길 18, 402호 대표전화.070-8809-9397
    개인정보책임자.박정아 통신판매업신고번호 제2017-서울서초-1765호 이메일 help@reportshop.co.kr
    copyright (c) 2009 happynlife. steel All reserved.